Background: Aortic stenosis (AS) is a structural heart disease primarily associated with ageing. For people with multiple co-morbidities, surgical treatment may not be a safe or feasible option. Transcatheter aortic valve implantation (TAVI) is indicated for patients with symptomatic AS who are at excessive risk for surgical valve replacement and are likely to derive significant benefit. Functional status can deteriorate during the time between referral and procedure because of the rapid disease progression of severe AS and varying wait-times for treatment in Canada. Aims: The purpose of this study was to examine changes in functional status between time of eligibility assessment and TAVI procedure date. Methods: An exploratory prospective cohort study was conducted to evaluate changes in functional status including gait speed, frailty scores and cognitive status. Results: Thirty-two patients participated in the study with median age 81 years. Functional status declined between time of eligibility assessment and time of TAVI: gait speed increased by an average of 0.53 s (standard deviation (SD)=1.0, p=0.01) and frailty scores increased by an average of 0.31 (SD=0.64, p=0.01). Patients waiting longer than six weeks for TAVI had a larger decline in gait speed than patients waiting less than six weeks (p=0.02). Patients living alone had a larger increase in frailty scores compared to patients living with another adult (p=0.05). Conclusion: Older adults with life-limiting AS are vulnerable to changes in functional status. In the absence of TAVI wait-time benchmarks, findings may be used to facilitate individualized care and management strategies and inform health-care policy.
Introduction
For an individual experiencing the progressive changes of ageing, 1 health and functional status can be significantly altered by the addition of a chronic disease or illness. 2 Aortic stenosis (AS) is a disease which causes progressive calcification or thickening of the aortic valve. It is found predominantly in elderly persons. When symptoms become severe, the disease progresses rapidly and may lead to death when untreated. 3 The treatment for severe AS is valve replacement, which has conventionally been performed as open heart surgery. 4 Surgical treatment may not be an option for older people burdened by multiple comorbidities because they may be too high risk for surgery.
Transcatheter aortic valve implantation (TAVI) has emerged as a safe and viable treatment option for this high risk population. In 2010, the results of a large randomized control trial demonstrated the safety and efficacy of TAVI and a 20% absolute reduction in one-year mortality in patients otherwise deemed inoperable. 4 The two year follow-up from this same trial was subsequently reported in 2012 and showed decrease rates of death, hospitalization, and improved valve hemodynamics and quality of life. 5, 6 One-year outcomes of TAVI for patients with inoperable AS have consistently demonstrated improved survival rates and quality of life outcomes. 7 Since the first transcatheter implantation, there has been a growing body of literature in the area of TAVI as researchers explore the efficacy and safety of this innovative procedure. 8 A large number of studies have been conducted to measure mortality, morbidity and clinical function yet very few have examined functional status as a study end point. 5, [9] [10] [11] Given that TAVI is being used for a predominantly elderly population, and that change in functional status can occur rapidly and have detrimental effects on level of independence and ability to fulfill daily roles, and ultimately affect quality of life, 12 it is important for clinicians to include measures of functional status as primary endpoints to guide case selection. 13 Researchers recognize the importance of measuring functional status in elderly individuals; however there is a lack of consensus regarding an operational definition of functional status and terms such as 'functional ability,' 'functional outcomes,' 'health status 'and 'quality of life' are often used interchangeably. 12, 14 These inconsistencies have necessitated the use of a variety of instruments to measure functional status in TAVI research studies including the New York Heart Association (NYHA) classification score, frailty indices, and patient-reported questionnaires. 11, [15] [16] [17] [18] Despite the absence of a standardized definition in the literature, viewing functional status with a broader, comprehensive approach which incorporates self-management skills, cognition, and emotional components has been reported in the literature. Moinpour et al. described functional status with a holistic approach and proposed that an accurate measurement of functional status would address all areas of functioning including; self-maintenance, ability to fulfill roles and social activities, physical health, emotional and intellectual status. 19 Wang described functional status as activities of daily life performed by an individual to meet the needs within all aspects of life including "physical, psychological, social, spiritual, intellectual and roles" (p.462). 20 These definitions imply that instruments that do not include multiple, holistic components would not truly capture a comprehensive assessment of functional status. Multiple validated instruments which measure the varied components of functioning may be required to obtain a comprehensive assessment. For an elderly individual, the presence of co-morbidities, worsening symptoms and other influencing factors could significantly contribute to changes in function while waiting to undergo valve implantation.
In countries which have a publicly funded health care delivery model, it is common for patients to wait extended periods of time to receive elective cardiac procedures. Wait-time data and strategies to optimize quality of life and post-operative outcomes have been studied in patients waiting for coronary artery bypass surgery. 21 However, literature reporting wait-time monitoring for TAVI patients is limited. In 2012, a multi-site study from the Netherlands showed patients waited for TAVI for a median of 71 days (interquartile range 30-119) from the time of acceptance to procedure. 22 In Canada, current wait-time data is unavailable due in part to the challenges associated with developing standardized definitions of time of referral and time of acceptance and the lack of evidence to understand the effects of waiting in this patient population. In the absence of specific wait-time benchmarks for TAVI, the provinciallevel governing body in the setting of the current study uses an urgency rating scale to apply to all heart surgeries performed in the province. Individuals with AS and the associated symptoms of angina, syncope, and heart failure are considered non-urgent and TAVI is classified as an elective procedure with a recommended maximum wait-time of six weeks. In 2005, the Canadian Cardiovascular Society Access to Care Working Group also published a report which recommended a maximum six-week wait-time for non-urgent patients undergoing conventional valvular heart surgery. 23 In countries that use a fixed-dollar single-payer healthcare delivery model, waiting lists are common practice; however, there is a paucity of literature regarding the effect of wait-times on TAVI patients' functional status. Thus, the purpose of this study was to explore the changes in functional status while waiting for TAVI.
Methods
An exploratory prospective, longitudinal cohort design was used to examine changes in functional status between the time of eligibility assessment and time of TAVI procedure.
Setting
This study took place at a TAVI clinic which serves as one of the largest referral centers for the province of British Columbia, Canada, and has treated over 1000 patients since inception of the program in 2005. Although TAVI programs within this province are growing in volume, and dynamic changes to improve access to services continue, patients must wait varying amount of time between when they are identified as candidates and when they have the procedure. In 2012, the wait-time for TAVI from time of eligibility assessment until the procedure date at this clinic was from 2-6 months depending on multiple variables, including clinical status, vascular access, native valve anatomy, or suitability for available valves. Operational challenges within the institution such as availability of allied and physician support services and scheduling of procedures also had an effect on wait-time.
Population
The sample included a prospective cohort of patients with severe AS eligible for TAVI between November 2012-March 2013. Exclusion criteria were; patients undergoing TAVI in conjunction with another surgical procedure, non-English speaking individuals, participants who scored less than 25/30 on the Mini-Mental State Examination (MMSE) at the time of eligibility assessment and those who scored less than 20/30 on the MMSE during the assessment of functional status by the researcher. A power analysis was performed to test for difference of means with a two-tailed t-test, and a power of 0.8 with an alpha of 0.05. In the absence of prior research examining the relationship between functional status change and severe AS, we allocated a large effect size (0.70) to the power analysis. This required a sample size of 33.
Procedure
Data from two time points were obtained (Time-1 and Time-2). Time-1 data were obtained retrospectively from the participants' TAVI eligibility assessment and included evaluation of the physical, cognitive, and social components of functioning that had been documented by the clinic nurse coordinator. When potential study participants were notified of acceptance by the clinic and agreed to undergo TAVI, a study invitation brochure and consent form was mailed to them. In this clinic, patients who were deemed eligible for TAVI were required to undergo a second pre-admission assessment which is performed 1-7 days prior to procedure. The researcher completed an assessment of functional status at the time of the patient's second pre-admission assessment (Time-2). The consent process occurred in-person between the researcher and participant prior to data collection at Time-2.
Approval for this study was granted from The University of British Columbia Providence Heath Care Research Ethics Boards (REBs) and Vancouver Coastal Health Research Institute. Consent was fully informed and ensured the dignity and autonomy of the participants was upheld. In this study, there were no personal risks to the participant but there were also no personal benefit.
Measurement instruments
As described previously, functional status is best viewed with a holistic approach to address physical, physiological, spiritual and social roles. For the small scope of this study, components such as health beliefs and patient-reported outcomes were not included. The authors' utilized three different instruments which combined provided a global assessment of functional status. The Canadian Study of Health and Aging Clinical Frailty Scale (CFS) measures an individual's ability to perform daily tasks and activity level, and was used to measure frailty. 24 The CFS ranges from 1-9 (from very fit to terminally ill and fully dependent or incapacitated), and is supported by a visual depiction and brief description of each score. 25 As a component of functional status, the CFS provides valuable information regarding abilities and limitations of daily activities as well as the extent of disease burden or symptoms which may cause limitations.
The second instrument was the 5-Meter Gait Speed test which was utilized to measure physical functioning. The use of gait speed to measure elderly individuals' functioning is emerging as a valid and reliable tool to assess functional status and as a predictor of mortality and morbidity, especially in the elderly population undergoing invasive cardiac procedures. 26, 27 In an unobstructed hallway, a 5 m distance was measured and marked. Participants began at the 0 m marking and were asked to walk at their usual, comfortable pace past the 5 m marking, with their usual mobility device if required. A stopwatch was used to time the distance it took from first step after the 0 m marking until first step after the 5 m line. If capable, participants were asked to perform the test three times; all sets of times were documented and used for statistical analysis.
Lastly, the MMSE was used to measure the cognitive functional capacity of participants. This tool consists of 11 questions which address orientation to time and place, short-term memory, calculation, immediate recall, language, and construct ability. 28 Each question is allotted a certain number of points and are added together to produce an overall score with 30 being the maximum which can be achieved. The MMSE is one of the most widely used screening tests for cognitive function and can provide a useful clinical tool to assess mental status changes. 29, 30 Other data collected included select patient characteristics such as; time from eligibility assessment until TAVI procedure, age, sex, living situation, left ventricular ejection fraction, NYHA classification, and vascular approach to TAVI (transapical or transfemoral). Patients who undergo the transapical approach have been reported to be more likely to have peripheral vascular disease, prior myocardial infarction, NYHA class I and II and are female. 31 Therefore, identifying a relationship between functional status change and vascular approach to TAVI was important to consider.
Statistical analysis
After exploring for normality of data, a paired t-test was used to explore changes to the MMSE scores between Time-1 and Time-2. A Wilcoxon signed rank test was used to assess 5-Meter Gait Speed test between Time-1 and Time-2 because data were skewed and kurtotic; The Wilcoxon signed rank test was also used for CFS between Time-1 and Time-2 because although the CFS is a ninepoint scale, our sample was restricted to patients with a small range of scores, and thus were treated as ordinal. One participant required a wheelchair for mobility and was unable to complete the gait speed assessment. After reviewing the data, two patients had gait speed scores that were not plausible and a data entry error was suspected, therefore these two cases were removed. To examine the relationship between patient characteristics and differences in gait speed and CFS scores from Time-1 to Time-2, Mann-Whitney U tests were used. Spearman's rho was used to examine the association between age and mean differences in gait speed and CFS scores.
Analyses were conducted with an interest in the effects of patient characteristics on functional status while waiting for TAVI. Select patient characteristics were dichotomized for statistical analysis. In the absence of established benchmarks for recommended maximum wait time (RMWT) for TAVI, we dichotomized wait-time as less or more than 42 days (6 weeks) from acceptance to procedure, as recommended by the provincial governing body. Living situation was dichotomized into; lives alone or lives with another adult (living with a spouse or other adult, or living in a care facility). This was based on previous research which had identified that individuals who live alone are more likely to demonstrate functional decline and are at an increased risk for health problems compared to those who live in supported environments. 32, 33 The measurement of left ventricular ejection fraction (LVEF) was dichotomized as lesser than or greater than 40% to differentiate participants with impaired cardiac function. NYHA functional class was categorized into: participants' with NYHA class I and II (none to mild symptoms and mild limitations), and those with NYHA class III and IV (symptoms ranging from marked to severe limitations due to symptoms of heart failure). 34 The range of the participants' ages in this study was between 64-93 years. Because of the complex relationship between age and an individual's well-being, age was analyzed as a continuous variable and not placed into categories. All statistical analyses were performed using the IBM SPSS Statistics for Windows, Version 21.0.
Results
Seventy-six patients were waiting for TAVI between November 5, 2012 and March 27, 2013 (Figure 1) . A total of 22 patients waiting for TAVI were deemed ineligible because they were: non-English speaking (n=3), had an MMSE score <25 at their time of eligibility assessment (n=10) or did not have Time-1 data (n=9). Although there were 54 eligible patients for this study, a total of 32 were enrolled and completed the study. Six patients were still waiting for TAVI at the time of study completion, six patients refused to participate, two patients died while on the wait list, and eight patients were not contacted. These latter patients were not contacted because three had already attended their pre-admission clinic (PAC) visit prior to the researcher being notified, three were inpatients at other facilities and two patients were not enrolled due to the researcher being unaware of their PAC appointment. The final sample size was 32.
Baseline characteristics
The sample included 32 participants with a mean age of 81 years (SD=8, range 64-93) of whom 14 (44%) were women and 18 (56%) were married. Participants waited an average of 69 days (i.e. almost 10 weeks) (SD=62, range 13-307, median 55) from the time of their eligibility assessment until time of TAVI (Table 1 ). The transfemoral approach was used for vascular access in 25 (78%) participants.
Functional status changes
On average, frailty scores worsened significantly from 4.25 out of 9 (SD=0.84) at baseline to 4.56 out of 9 (SD=0.72) at the time of the procedure, representing an absolute mean difference of −0.31 (t= -2.74, z=2.5, p=0.01) ( Figure 2 ). The clinical significance of this change is important to consider because worsening frailty scores indicate a decline in the ability to perform activities of daily living and loss of independence. Worse frailty has been associated with a higher probability of requiring institutional care 35 and increased one-year mortality in older adults undergoing TAVI. 16 MMSE scores did not change significantly between the two time points (mean difference=0.22, t=0.865, df 30, p=0.394, 95% confidence interval (CI): -0.31-0.75).
Gait speed worsened from 7.3 s (SD=2.9) at Time-1 to 7.5 s (SD=2.8) at Time-2 with a mean absolute increase of 0.18 s (n=32) although this was not statistically significant (z=1.65, p=0.09). Two participants had an almost 5 s improvement in their gait speed between Time-1 and Time-2 (-4.7 s; and −4.9 s). This may have been due to measurement error at baseline; therefore we examined the gait speed scores with the extreme outliers excluded. When the outliers were removed, the time it took to walk 5 m at Time-2 increased significantly from 6.9 s to 7.5 s (mean difference 0.53 s; n=29) (z=2.53, p=0.011)). Even though power was diminished and potential for Type II error increased with the removal of the outliers, the result was statistically significant.
Predictors of change in functional status. We found a significant relationship between the change in frailty score and participants' living situations ( Table 2) . Participants who lived alone demonstrated worsened frailty scores (mean difference of 0.6) than participants who lived with another adult (mean difference of 0.1). The differences between the mean difference was statistically significant (differ-ence=0.5, U=72.5, z= −1.96, p=0.05), indicating participants who lived alone became more frail and scored higher on the CFS while waiting for TAVI. Comparing the difference between MMSE scores and the selected patient characteristics did not yield any statistically significant changes (data not shown).
We included all participants in the gait speed subanalysis and found that participants who waited 42 days or less had no change in their gait speed (mean difference 0 s), whereas participants who waited more than 42 days had an increased gait speed (mean difference of 0.8 s) resulting in a mean increase of 0.8 s for patients who waited more than 42 days compared to those who waited less than 42 days (U=145.5, z=2.3, p=0.02; see Table 3 ).
Discussion

Decline in functional status while waiting for TAVI
This study suggested that elderly patients with severe AS had a decline in their functional status while waiting for TAVI. Frailty scores and gait speed worsened. Severe AS is a life limiting disease associated with rapid changes in symptom burden and mortality within 18 months to four years, 3 however this is one of few studies examining the effects of the disease trajectory on functional status. These results are consistent with a study by Van Geldorp et al. which showed that patients with severe AS who had not yet been referred for surgical intervention had significantly lower physical and social functioning than the general population. 36 Although Van Geldorp et al. used a patientreported measurement, this study adds to the evidence by providing data that gait speed and frailty deteriorate while waiting for TAVI. It is possible that there is an association between the disease progression of AS, worsening symptoms and functional status. An evidence-based threshold for TAVI wait-times is not established. This research study provides exploratory and novel results for TAVI centers who routinely manage clinical triage, risk stratification and wait-time management. The inclusion of a multidimensional functional assessment and arising evidence that patients may experience a significant decline in function while waiting can inform clinicians and health care administrators to optimize pre-procedure planning and patient outcomes. In a small pilot study by Sawatzky et al., the researchers aimed to show the feasibility of providing a prehabilitation program to patients waiting for coronary artery bypass graft (CABG). 37 Those who participated in the exercise program showed significant improvement in walking distance and gait speed at preoperative and three month post-operative assessment compared to baseline. A similarly designed program aimed at optimizing the functional status of patients waiting to undergo TAVI could provide improved short and long term outcomes.
Correlation of functional status with patient characteristics
Results of this study showed select patient characteristics had a positive relationship with changes in functional status. Individuals who lived alone are more likely to become more frail while waiting for TAVI than those who lived with another adult, spouse or in an assisted-living facility. Similar results have been shown in the literature such as those described by Mor et al. who found elderly adults who lived alone were more likely to demonstrate functional decline. 32 Worobey also reported an increased risk for health problems and institutionalized in older adults who lived alone. 33 Recognizing that older adults living alone are at higher risk of experiencing functional decline is important as our population ages. The addition of a chronic disease, such as AS provides increased risks and complications for older adults living alone. In a systematic integrative review, it was reported that older people with chronic illnesses and living alone were more vulnerable because of limited resources, lack of social support, or challenges faced with making independent decisions regarding management of their disease. 38 Wait-time between eligibility assessment and TAVI was found to have a positive relationship with functional status decline. Individuals who waited longer than six weeks for TAVI had statistically significantly slower gait speed at the time of procedure compared to those who waited less than six weeks, even with this small sample. This study supports the need to establish evidence-based benchmarks regarding urgency ratings and wait-times for TAVI patients, including the time required to complete the multiple diagnostic assessments, and the time waiting for the procedure. Although mortality was not recorded in the study cohort or measured as an outcome objective, evidence demonstrating that functional decline is a predictor of mortality and morbidity may indicate that excessive waiting for TAVI may be unsafe for some patients. Wijeysundera et al. applied a discrete event modelling analysis to the data obtained in a 2012 randomized control trial to evaluate the impact of varying wait-times for TAVI. 39 Results showed that one-year and wait-time mortality were higher for patients with wait-times greater than 60 days. Although this was a simulated model, the data included more than 1000 patients who received TAVI and is worthy of note.
Wait-time benchmarks can be used to help monitor access and outcomes, support the provision of equitable access to care, improve resource management, and inform risk stratification methods. Our findings may suggest that the TAVI population requires individualized risk stratification to consider the urgency of the procedure and takes into account the findings of a comprehensive functional status assessment. The development of wait-time benchmarks based on the limited epidemiological data currently available is warranted.
Limitations
The findings of the study must be considered with the limitations of the sample size, the reliability and validity of measuring gait speed, exclusion criteria, and use of the MMSE to assess cognitive function. Obtaining a larger sample from other sites that perform TAVI would have provided a more representative sample of the population. In one analysis we excluded gait speed measurements for two participants because they were extreme outliers and we suspected that baseline data collection may have been inaccurate. However, when we included all data in the subanalyses, patients who lived alone were more likely to have an increase in their gait speed. Future research should ensure consistent measurement of baseline and subsequent scores for all data. The MMSE was used in this study to assess changes in cognitive function between two time points and exclusion criteria included any potential participants' who obtained a score of less than 25 on the MMSE at Time-1. Ten individuals were deemed ineligible to participate because of these criteria. Valuable information regarding functional status could have been obtained from these individuals even if the MMSE score truly represented cognitive impairment or was due to their language spoken or their education level.
The purpose of using the MMSE for this study was a pragmatic decision reflecting clinical practice however; the scoring system did not accurately detect clinically meaningful changes. Orientation to specific locations can be irrelevant to individuals who were assisted to attend their clinic visit by a support person and calculation and language may reflect education level. Another validated tool frequently used to assess cognitive impairment is the Montreal Cognitive Assessment (MoCA). This 30-point measurement tool takes slightly longer to administer than the MMSE because it includes a broader range of cognitive domains. 40 Studies have shown the MoCA to have higher sensitivity to mild cognitive impairment, to assess higher levels of executive functioning, to encompass a larger range of cognitive fields, and to demonstrate high levels of test-retest reliability. 41, 42 Clinically relevant assessments and research generating information could be obtained with an instrument such as the MoCA.
Recommendations for future research
It is important for TAVI research to focus on functional status as a component of pre-procedure assessment, risk stratification, and outcome variable. The inclusion of measures of functional status within TAVI research is evident. 16, 43 However, there is an absence of a standardized definition of functional status and functional components are often not clearly defined. Future research could inform the appropriate measure of functioning which would facilitate outcome evaluation and provide specific strategies for treatment interventions. Research incorporating changes in functional status could provide evidence based data used to develop TAVI wait-time benchmarks. Duplicating this study in a larger sample could validate the exploratory findings in this study. The addition of a qualitative approach to explore patients' perception of their functional status while waiting for TAVI would provide valuable information and inform future research in this new era of the management of structural heart disease.
Conclusion
We found that functional status decline occurred while waiting for TAVI and that individuals living alone and those waiting longer than six weeks experienced significantly worse decline. Although a small sample size was obtained, these results have implications for those undergoing TAVI. Nursing care processes and educational initiatives for care providers, patients and families, which are aimed at optimizing functional status while waiting for TAVI are important. Providing strategies to prevent functional deconditioning while waiting for TAVI will improve overall well-being and lead to improved patient outcomes. In addition, future research should ensure that a comprehensive evaluation of functional status is included in pre-operative assessments, risk stratification, and outcome measures. Lastly, standard benchmark wait-times ought to be adopted to minimize the impact on functional decline on this vulnerable patient population.
Implications for practice
• • Re-assessment for patients whose wait-time exceeds six weeks would allow for early referrals to social work, physical therapy, dieticians and individualize plans of care. • • Evidence based benchmarks for wait-time will help monitor outcomes, support the provision of equitable access to care and inform risk stratification. • • Individuals who live alone require strategies and specific interventions aimed at managing their symptom burden and slowing the trajectory of functional decline. • • Clinicians may be challenged with the decision of choosing several instruments to measure the multi-dimensions of functional status.
